Clinical Trial Update: Gene Therapy for Post-Operative Atrial Fibrillation [Phase 1]

View source ↗

Summary

Phase 1 gene therapy trial for postoperative atrial fibrillation has been withdrawn. No results have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Postoperative Atrial Fibrillation

Drugs mentioned

• Gene therapy (unspecified)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Atrial Fibrillation, Post-operative Atrial Fibrillation | Phase 1 | Status: WITHDRAWN